Portfolio Manager since 2013
International Small Cap
-
YTD Return
Return is shown net of fees. See performance below for additional disclosure.
-
Total Assets
Profile
The Cambiar International Small Cap strategy is a diversified portfolio that invests primarily in small-cap companies based outside of the U.S. The starting universe for the strategy includes any international business with a market cap between $500 million to $5 billion. Cambiar’s quality and value bias will result in a portfolio overweight to developed markets, and subsequent underweight in emerging markets.
Portfolio Construction:
- 40-50 International stocks
- Country Limit: 25% (at cost)
- Emerging Markets Limit: 15% (at cost)
Key Facts
- Inception Date
- 6/30/2013
- Minimum
- $20 MM
Portfolio Managers
-
-
Portfolio Manager since 2013
Performance
Inception Date: 6.30.2013. The performance information depicted above represents Cambiar’s International Small Cap Composite. Returns are presented gross (g) and net (n) of management fees. Gross and net returns have been reduced by transaction expenses. Net returns are also reduced by actual investment advisory fees and other expenses that may be incurred in the management of the account. Net of fees performance reflects a blended fee schedule of all accounts within the International Small Cap Composite. Cambiar clients and mutual fund investors may incur actual fee rates that are greater or less than the rate reflected in this performance summary. Results are reported in U.S. dollars.
Performance results for the International Small Cap Composite are evaluated against the MSCI EAFE Small Cap Index. The MSCI EAFE Small Cap Index is a free float-adjusted, market capitalization-weighted index that is designed to measure small cap representation across developed market equity performance, excluding the U.S. & Canada. The index assumes no management, custody, transaction or other expenses. The MSCI EAFE Small Cap Index is a broadly based index that reflects the overall market performance and Cambiar’s returns may not be correlated to the index. The index is unmanaged and one cannot invest directly in an index. Cambiar’s performance and the performance of the MSCI EAFE Small Cap Index include the reinvestment of all income. Benchmark returns are net of withholding taxes. Cambiar typically follows each custodian’s treatment of tax withholding and therefore dividends may be presented as gross or net of dividend tax withholding depending on the custodian’s treatment. Withholding taxes may vary according to the investor’s domicile. Performance is preliminary; please contact us for finalized figures. As with any investments, there are risks to be considered. Past performance is no indication of future results.
View Cambiar’s GIPS compliant presentations here.
Composition
Top 10 holdings
Sector Weights (%)
Attributes
RISK STATISTICS
Active Share
Top Countries (%)
Disclosures
Data is provided for a representative account as of June 30, 2019. Portfolio holdings, characteristics, country breakdown, and sector weightings change over time and may differ between clients based upon their investment objectives, financial situations and risk tolerances. Cambiar makes no warranty, either express or implied, that the weightings shown will be used to manage your account. The securities presented do not represent all of the securities purchased, sold, or recommended by Cambiar and the reader should not assume that investments in the securities identified were or will be profitable. The information provided on the page should not be considered a recommendation to buy or a solicitation to purchase or sell any particular security. There can be no assurance that an investor will earn a profit or not lose money. There can be no assurance that the portfolio will continue to hold the same position in companies described herein, and the portfolio may change any portfolio position at any time. As with any investments, there are risks to be considered. Past performance is no indication of future results.
The one year forecast is included for illustrative purposes and accordingly, no assumptions or comparisons should be made based upon these ratios. Risk statistics are based off a five-year time frame. Portfolio characteristics are based upon third-party sources that are deemed to be reliable, however, Cambiar does not guarantee its accuracy or completeness.
Total Assets represents assets under management for the strategy and are subject to change. Minimums represent intended/proposed minimums for institutional clients and are subject to change.
Source: MSCI. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used to create indices or financial products. This report is not approved or produced by MSCI.
Definitions:
Active Share – a holdings-based measure of active management representing the percentage of securities in a portfolio that differ from those in the benchmark index.
Price/Earnings (F1Y) – a calculation that divides the current share price by the estimates of earnings in the next four quarters.
Debt/Equity – Long Term is a calculation that takes interest-bearing, long-term debt divided by shareholder equity.
EPS Growth – Long Term is a calculation that takes the company’s estimated profits for five years divided by the outstanding shares.
Alpha – a measure of risk-adjusted performance.
Beta – a measure of risk in relation to the market or benchmark.
R-Squared – a measure of how closely a portfolio’s performance correlates with the performance of a benchmark index
Sharpe Ratio – a direct measure of reward-to-risk and is calculated by subtracting the risk-free rate from the rate of return for a portfolio and dividing the result by the standard deviation.
Standard Deviation – a statistical measure of historical volatility; a measure of the extent to which numbers are spread around their average.
Commentary
Global Markets – 2Q19 Review
Global equities continued their upward trajectory, posting modest gains in the second quarter. The back-to-back quarterly advances results in a mid-teen return for most averages as we reach the mid-point of 2019. Company-specific fundamentals took somewhat of a backseat to macro considerations in the quarter, as investors keyed in on heightened trade tensions and changes in central bank monetary policy. While the aggregate performance for stocks give the appearance of a relative placid market environment, the underlying pin action in stocks during the quarter told a more volatile story.
As we reach the halfway mark of the year, there are a number of notable divergences in play that are worth contemplating. U.S. stocks (as measured by the S&P 500 Index) are approaching prior high-water marks, yet segments of the yield curve are inverted – often a precursor to a recession. Consumer spending remains high, yet corporate capex and business confidence readings offer a more sober outlook. On an investment style basis, growth stocks are leading the way, while more economically-sensitive value stocks continue to lag. The year-to-date rally has helped to erase the losses that were sustained in 2018, and Cambiar is cautiously optimistic that equities continue to offer an attractive risk/reward profile relative to other asset classes. That said, this constructive view is largely dependent on the expectation for the U.S. and China to reach a compromise in their ongoing trade talks.
There was a classic ‘bad news is good news’ response by investors in the quarter. Stocks sold off in May on concerns about the negative impact of trade on corporate earnings, only to rally in June after global central banks made it clear they were willing to respond with additional easing measures to sustain the economic recovery. After implementing four rate hikes in 2018, the U.S. Federal Reserve has since shifted to a more dovish posture – indicating the potential for rate reduction(s) in the coming months. Central banks in Europe, Australia, Japan, the United Kingdom, and India indicated a similar willingness to make accommodative moves in an attempt to maintain/stimulate growth in their respective economies. Given that central banks remain at or near ultra-accommodative levels almost 10+ years into the current recovery, the obvious question is what measures policymakers will have at their disposal when the next down cycle is upon us?
Certain information contained in this communication constitutes “forward-looking statements”, which are based on Cambiar’s beliefs, as well as certain assumptions concerning future events, using information currently available to Cambiar. Due to market risk and uncertainties, actual events, results, or performance may differ materially from that reflected or contemplated in such forward-looking statements. All information provided is not intended to be, and should not be construed as, investment, legal or tax advice. Nothing contained herein should be construed as a recommendation or endorsement to buy or sell any security, investment or portfolio allocation. Securities highlighted or discussed have been selected to illustrate Cambiar’s investment approach and/or market outlook. The portfolios are actively managed and securities discussed may or may not be held in client portfolios at any given time, do not represent all of the securities purchased, sold, or recommended by Cambiar, and the reader should not assume that investments in the securities identified and discussed were or will be profitable. As with any investments, there are risks to be considered. All material is provided for informational purposes only and there is no guarantee that the opinions expressed herein will be valid beyond the date of this commentary.
Any characteristics included are for illustrative purposes and accordingly, no assumptions or comparisons should be made based upon these ratios. Statistics/charts are based upon third-party sources that are deemed reliable; however, Cambiar does not guarantee its accuracy or completeness. As with any investments, there are risks to be considered. Past performance is no indication of future results. All material is provided for informational purposes only and there is no guarantee that any opinions expressed herein will be valid beyond the date of this communication.